Recent Press Releases

NIH prepares by funding new bird flu vaccine studies

NIH prepares by funding new bird flu vaccine studies Group Health helps protect people from deadly flu seen in China last spring September 18, 2013 Seattle, WA—Scientists at Group Health...

NIH begins testing H7N9 avian influenza vaccine candidate

NIH begins testing H7N9 avian influenza vaccine candidate Possible role for adjuvants to be examined September 18, 2013 Researchers at nine sites nationwide have begun testing in humans an...

ISA Pharmaceuticals Initiates Phase I/II Clinical Trial of ISA101 in Patients with Anal Intraepithelial Neoplasia (AIN)

ISA Pharmaceuticals Initiates Phase I/II Clinical Trial of ISA101 in Patients with Anal Intraepithelial Neoplasia (AIN) Therapeutic vaccine against Human Papilloma Virus type 16 (HPV16) tested in...

LA JOLLA INSTITUTE SCIENTIST IDENTIFIES HELPER CELLS THAT TRIGGER POTENT RESPONSES TO HIV

LA JOLLA INSTITUTE SCIENTIST IDENTIFIES HELPER CELLS THAT TRIGGER POTENT RESPONSES TO HIV Member of National AIDS Vaccine Consortium Pinpoints Helper T Cells Important for AIDS Vaccine Development...

Nanoly Bioscience to develop CU-Boulder vaccine stabilization technology

Nanoly Bioscience of Boulder and the University of Colorado recently entered into an option agreement that will enable the startup company to develop a technique for protecting vaccines during...

Vaccine campaign in sub-Saharan Africa reduces meningitis by 94 per cent

Meningitis can be caused by several species of bacteria, but one of the most important is the meningococcus. In a region of sub-Saharan Africa known as the African meningitis belt, stretching from...

Two-Day Conference on Developments in Cancer Vaccines and Gene Therapy

Two-Day Conference on Developments in Cancer Vaccines and Gene Therapy Cancer Vaccines and Gene Therapy Meeting in Philadelphia area Oct 3-4, 2013 September 09, 2013 10:49 PM Eastern Daylight...

BCC Research Publishes A New Report On Global Markets For Vaccine Technologies

BCC Research Publishes A New Report On Global Markets For Vaccine Technologies. The global market for vaccine technologies was valued at $33.6 billion in 2012. BCC Research expects the market to...

Valneva Announces Positive Phase I Results for its Clostridium Difficile Vaccine Candidate

Valneva Announces Positive Phase I Results for its Clostridium Difficile Vaccine Candidate - Primary and secondary objectives met in clinical trial in elderly subjects to prevent Clostridium...

MENOMUNE® IS THE FIRST QUADRIVALENT MENINGOCOCCAL VACCINE PREQUALIFIED BY THE WHO

MENOMUNE® IS THE FIRST QUADRIVALENT MENINGOCOCCAL VACCINE PREQUALIFIED BY THE WHO - Prequalification Makes the Vaccine Eligible for Purchase by United Nations Agencies - Lyon, France -...

Merck's Durham Site Receives U.S. FDA Licensure for Varicella Bulk

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture bulk...

Thai-US partnership confirms renewed push on HIV vaccine

Thai-US partnership confirms renewed push on HIV vaccine On 29 August at the AIDS Vaccine Efficacy Consortium (AVEC) Summit for an AIDS-Free Generation in Thailand, a Thailand-United States...

Novartis begins shipment of seasonal influenza vaccines to US market

Novartis begins shipment of seasonal influenza vaccines to US market - Novartis plans to ship a minimum of 30 million doses of its seasonal influenza vaccines to US customers for the 2013-2014 season...

Sanofi Pasteur's Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older

Sanofi Pasteur's Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older - Efficacy trial in more...

Northwestern Medicine Enrolls First Participant in Midwest for Research Study of Personalized Vaccine for Aggressive Brain Tumors

Northwestern Medicine Enrolls First Participant in Midwest for Research Study of Personalized Vaccine for Aggressive Brain Tumors August 14, 2013 Chicago - Randomized phase II trial will investigate...

Flu vaccinations will be available every day at CVS/pharmacy and MinuteClinic, including High-Dose flu shot for senior population

Flu vaccinations will be available every day at CVS/pharmacy and MinuteClinic, including High-Dose flu shot for senior population WOONSOCKET, R.I., Aug. 15, 2013 /PRNewswire/ --A new survey from...

Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models

Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models BLUE BELL, Pa., Aug. 15, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO)...

Patient Trial of Immunization to Treat Alzheimer's Disease Begins at Cedars-Sinai

Patient Trial of Immunization to Treat Alzheimer's Disease Begins at Cedars-Sinai Newswise — LOS ANGELES (Aug. 12, 2013) – Cedars-Sinai Medical Center has launched a Phase I clinical...

Vaccine Market Worth $84.44 Billion by 2022

Vaccine Market Worth $84.44 Billion by 2022 DALLAS, August 8, 2013 /PRNewswire/ -- The "Vaccine Market - By Technology & Types, Trend Analysis By Various Classes - Live / Attenuated,...

Immunovaccine Secures $5 Million Loan to Support Clinical Stage Cancer Vaccines and DepoVax™ Platform

Immunovaccine Secures $5 Million Loan to Support Clinical Stage Cancer Vaccines and DepoVax™ Platform Support from Province of Nova Scotia Offers Validation of IMV Clinical Programs; Ensures...